Net Income

A new power standard is emerging to feed AI's insatiable energy needs, promising massive cost savings and efficiency gains for next-gen data centers.

Discover how a brand born from cancer research is reshaping skincare with its launch at Ulta Beauty, making advanced biotech formulas accessible to everyone.

AI genomics firm partners with two major US health systems, aiming to accelerate cancer and rare disease diagnostics for 60,000 patients annually.

With 100+ new locations in 2025, Smile Doctors' rapid expansion signals a major shift. What does this mean for independent doctors and patient care?

A new report shows many Americans are ditching pricey V-Day gifts to pay down debt, revealing a deep economic divide reshaping how we celebrate love.

Fresh off a strategic rebrand and a record-breaking year, Potomac Bancshares is courting investors and cementing its role as a Mid-Atlantic banking leader.

Cities are trading 1970s-era tech for smart systems that slash emergency response times, improve safety, and even lower insurance rates for residents.

A new report reveals a 38% drop in ransomware, but the danger is evolving. Hackers now prefer silent, long-term intrusion over noisy encryption.

Bolstered by a top regulatory expert and unique veterinary data, Vivos Inc. is set to file for human trials of its precision injectable cancer treatment.

The expanded credit facility provides fintech leader Upgrade with enhanced capital to scale its consumer lending platform, fueling its rapid market expansion.

A new webinar explores how integrating data into EHRs is overcoming major barriers to improve mental health outcomes. Learn how this tech revolutionizes care.

Kratos will compete in a live fly-off for a massive military contract aimed at fielding 350,000 one-way attack drones, reshaping modern warfare.

TruGolf accelerates its stock repurchase program, signaling faith in its future as it unveils new AI-powered tech in a booming indoor golf market.

ARS Pharma's neffy challenges the EpiPen with new data on efficacy, cost-effectiveness, and patient preference, promising a less intimidating allergy emergency.

Celularity Inc. has secured a $12.2M cash injection by selling tax losses, a move set to accelerate its cutting-edge longevity and regenerative medicine pipeline.

A new survey shows most family firms expect a leadership change soon, but few are prepared, creating a high-stakes gap between intent and action.

With two high-profile board appointments, Stellaromics signals its ambition to dominate the 3D spatial omics market with its advanced Pyxa™ platform.

A new partnership between GeminiBio and Tolemy Bio introduces aiMOS™, an AI-powered service designed to cut costs and boost consistency in cell therapy production.

A new report, based on $34B in spend data, uncovers massive waste in SaaS, cloud, and mobile, offering a playbook for CIOs to regain control.

With $4.5M donated last year, MAC's iconic lipstick program has evolved from an AIDS crusade into a global force for racial, gender, and environmental justice.